IFN-γ信号使黑色素瘤细胞对BH3模拟物敏感
该研究评估了PD-1抑制剂治疗后进展的黑色素瘤转移灶来源的短期细胞系(PD1 PROG细胞),发现IFN-γ通过改变凋亡调节因子MCL-1、NOXA和BAK的积累与相互作用使黑色素瘤细胞凋亡致敏;加入促凋亡BH3模拟物药物可使PD1 PROG细胞对IFN-γ或自体免疫细胞活化诱导的凋亡敏感。
要点
- IFN-γ通过改变MCL-1、NOXA和BAK的积累与相互作用使黑色素瘤细胞凋亡致敏。
- BH3模拟物药物使PD1 PROG黑色素瘤细胞对IFN-γ或自体免疫细胞活化诱导的凋亡敏感。
- 该发现为黑色素瘤联合治疗提供了可转化策略。
核心结论
- IFN-γ信号使黑色素瘤细胞对BH3模拟物敏感,为黑色素瘤联合治疗提供了可转化策略。
研究设计与样本
- 研究评估了PD-1抑制剂治疗后进展的黑色素瘤转移灶来源的短期黑色素瘤细胞系(称为PD1 PROG细胞)。
主要发现
- IFN-γ通过促进凋亡调节因子MCL-1、NOXA和BAK的积累与相互作用改变,使黑色素瘤细胞凋亡致敏。
- 加入促凋亡BH3模拟物药物使PD1 PROG黑色素瘤细胞对IFN-γ或自体免疫细胞活化诱导的凋亡敏感。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immunotherapy targeting PD-1 and/or CTLA4 leads to durable responses in a proportion of patients with melanoma. However, many patients will not respond to these immune checkpoint inhibitors, and up to 60% of responding patients will develop treatment resistance. We describe a vulnerability in melanoma driven by immune cell activity that provides a pathway towards additional treatment options. This study evaluated short-term melanoma cell lines (referred to as PD1 PROG cells) derived from melanoma metastases that progressed on PD-1 inhibitor-based therapy. We show that the cytokine IFN-γ primes melanoma cells for apoptosis by promoting changes in the accumulation and interactions of apoptotic regulators MCL-1, NOXA, and BAK. The addition of pro-apoptotic BH3 mimetic drugs sensitized PD1 PROG melanoma cells to apoptosis in response to IFN-γ or autologous immune cell activation. These findings provide translatable strategies for combination therapies in melanoma.
引用
- Ming Z, Lim SY, Stewart A, et al. IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics. J Invest Dermatol. 2023. PMID: 36736995. doi:10.1016/j.jid.2023.01.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。